Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Viking Therapeutics, Inc. (VKTX) had Return on Investments of -12.73% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-90.79M |
|
-- |
|
-- |
|
$98.56M |
|
$-98.56M |
|
$7.77M |
|
$-90.79M |
|
$-90.80M |
|
$-90.79M |
|
$-90.79M |
|
$-90.79M |
|
$-90.80M |
|
$-98.56M |
|
$-100.47M |
|
112.32M |
|
112.32M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$738.70M |
|
-- |
|
$0.71M |
|
$739.41M |
|
$26.07M |
|
-- |
|
$0.32M |
|
$26.39M |
|
$713.03M |
|
$713.03M |
|
$713.03M |
|
112.45M |
|
| Cash Flow Statement Financials | |
$-193.40M |
|
$265.78M |
|
$1.34M |
|
$26.68M |
|
$100.38M |
|
$73.70M |
|
$32.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-193.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.73% |
|
-12.73% |
|
-12.28% |
|
|
Return on Investments |
-12.73% |
$6.34 |
|
$-1.72 |
|
$-1.72 |
|